Genetic association analysis using weighted false discovery rate approach on Genetic Analysis Workshop 18 data by Xin Qiu et al.
PROCEEDINGS Open Access
Genetic association analysis using weighted false
discovery rate approach on Genetic Analysis
Workshop 18 data
Xin Qiu1, Xiaowei Shen1, Osvaldo Espin-Garcia1, Abul Kalam Azad2, Geoffrey Liu1,2,3, Wei Xu1,3*
From Genetic Analysis Workshop 18
Stevenson, WA, USA. 13-17 October 2012
Abstract
In a genome-wide association study, association between disease trait and hundreds of thousands of genetic
markers are tested. Several methods have been proposed to control the false discovery rate in such high-
throughput data to adjust for multiple hypotheses testing. For Genetic Analysis Workshop 18, we applied the
method of false discovery rate control with p value weighting on family-based association tests on quantitative
trait to detect association between single-nucleotide polymorphisms (SNPs) and mean arterial pressure. This
method can improve statistical power by incorporating independent but relevant information about the research
objective. Using the real genetic and phenotype data of chromosome 3 from Genetic Analysis Workshop 18, 1 SNP
from gene CACNA2D3 was found to have significant association with mean arterial pressure.
Background
Recent developments in technologies have made it possi-
ble to collect a large amount of data and perform thou-
sands of statistical tests on the data. A lot of methods have
been proposed to control multiple testing. The family-wise
error rate control method is too stringent. The false dis-
covery rate (FDR) method proposed by Benjamini and
Hochberg [1] is more powerful but it treats all the tests
equally without any adjustment. Genovese et al proposed
the weighted false discovery rate (WFDR) control method
[2] to obtain an FDR-adjusted p value by incorporating
prior information about the hypotheses. For genome-wide
association studies, the p values for multiple testing can be
adjusted by the results from previous genetic linkage study
with improved power [2].
In Genetic Analysis Workshop 18 (GAW18), a family-
based association test study was conducted to identify
single-nucleotide polymorphisms (SNPs) that have signif-
icant association with blood pressure, a major cardiovas-
cular and heart disease risk factor. Current genome-wide
association studies have identified several genes that are
associated with blood pressure or hypertension [4,5].
With no access to previous linkage analysis study, we
extended the WFDR control method to adjust p values
from family-based association test by independent infor-
mation from population based association. We find this




The GAW18 data set consists of 1043 individuals from
20 Mexican American pedigrees from Type 2 Diabetes
Genetic Exploration by Next-generation sequencing in
Ethnic Samples (T2D-GENES) Project 2. Real genetic
data for 472,049 SNPs on odd-numbered autosomes are
available for 959 individuals. A total of 932 individuals
have real phenotype data, including sex, age at examina-
tion, year of examination, systolic blood pressure (SBP),
diastolic blood pressure (DBP), antihypertensive medica-
tions, hypertension diagnosis, and tobacco smoking for
up to 4 time points. The maximal set of genetically unre-
lated individuals consists of 157 individuals, among
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which 142 individuals have real genotypes. Our study
focused on real genetic data for chromosome 3 only.
Definition of outcome
As a result of the high missing rate in real phenotype
data of GAW18 for second or later examinations, all the
analysis was based on phenotype information for the
first examination only. For each individual i, we define
the quantitative phenotype as mean arterial pressure
(MAP) [6], which can be determined by baseline SBP
and DBP as follows:
Yi =
2 × DBPi + SBPi
3
(1)
MAP is a term often used in medicine to describe an
average blood pressure by combining DBP and SBP in
an individual.
Statistical analysis
We applied adjusted linear regression models to each of
the SNPs in chromosome 3 within unrelated individuals
to conduct a population-based association test. Family-
based association tests for this quantitative trait were
applied to all the trio families using the quantitative
transmission disequilibrium test (QTDT). We then
applied the WFDR control by incorporating p values
from the population-based association test as weights to
control the FDR of family-based association tests. The
following material describes our analysis steps.
Population-based association analysis
Apply the adjusted linear regression model to the unre-
lated subjects. The adjusted covariates are sex, age at
baseline examination, use of medications, and principal
component from population stratification. Thus the
model fitted for each SNP is as follows:
MAP = α + β1 × sex + β2 × age + β3 × medication + β4 × PC + γjXj (2)
where Xj represents the jth SNP. We denote p value
for jth SNP as Ppop,j and then use this information as
weights to adjust p values from family-based association
tests in the later step.
Family-based association analysis
Break the large pedigrees into trios. A trio family consists
of 2 genotyped parents and 1 offspring. The offspring
should have both genotype and phenotype information.
Apply family-based association tests for quantitative trait
by PLINK [3] on MAP among those trio families. We
denote p value for jth SNP as Pfam,j for j = 1, 2, . . . ,m and
adjust multiple testing according to Benjamini-Hochberg
[1] method. Let P(1) < P(2) < . . . < P(m) be ordered
p values from m hypothesis tests, then Benjamini-
Hochberg procedures rejects any null hypothesis for any
P ≤ T with
T = max
{






Apply WFDR control to adjust Pfam,j. We first assign
weights Wj proportional to 1/Ppop,j to null hypothesis for
each SNP such that
∑Wj












to get Q(1) < Q(2) < . . . < Q(m). Then we apply the
Benjamini-Hochberg procedure in equation (2) at level α
to each Q(j) and thus obtain adjusted p values.
Power evaluation by simulations
To evaluate the performance of the WFDR approach,
simulations were implemented. First, we simulated 250
trio families with a single quantitative phenotype, 49,999
SNPs were simulated under the null hypothesis in which
each SNP is independent to the phenotype; 1 SNP was
simulated under the alternative hypothesis to be asso-
ciated with the phenotype. The association of the pheno-
type and genotype was based on the linear relationship
phenotype = β ∗ genotype + α + ε (5)
where α is a constant, genotype is an ordinal variable
of the SNP genotype (0 for major/major genotype, 1 for
major/minor genotype, and 2 for minor/minor geno-
type), ε is random error, which follows normal distribu-
tion, and β is the coefficient that reflects the effect size
of relationship between genotype on phenotype. We
also simulated 250 independent individuals for each
SNP; each SNP was used to test population-based
association.
Different effect sizes were simulated for the associated
SNP. We applied 1000 replications. We also applied both
the ordinary FDR approach and the WFDR approach on
the simulated 250 trio families. Empirical p values were
calculated by counting how many replications were sig-
nificant after applying the ordinary FDR or WFDR
approach under different effect sizes.
Results
Genetic quality control
Among all family members, 58% of are females and the
median MAP is 88, ranging from 58 to 154. Among
unrelated individuals, 58% are females and the median
MAP of all unrelated individuals is 89 (70 to 126).
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For genetic data, we started quality control with
65,460 SNPs of chromosome 3 using PLINK [3] in both
959 family members and 142 unrelated individuals. We
removed 4641 SNPs with a missing rate greater than
0.05 and 11,414 SNPs with a minor allele frequency
smaller than 0.05. This left us with 49,407 SNPs and
959 family members. We further applied quality control
among unrelated subjects. Remaining in the sample
were 42,727 SNPs of 132 individuals, as 9 individuals
with a high missing rate were excluded and 1 individual
was deleted as an outlier by comparing to HapMap
data. Principal components analysis [7] was used to
adjust for the population stratification effect among
unrelated individuals. After merging SNPs from family
based and population based samples, we end up with
40,359 SNPs. Then we broke the family into trio
families, resulting in 260 eligible trio families for the
QTDT.
Statistical results
Our results for both family-based and population-based
association tests for MAP were obtained by PLINK.
p Values of each SNP and corresponding positions were
provided in the Manhattan plots (Figure 1). The genetic
model applied on each SNP was the additive model.
The population-based association analysis yielded no
significant signal at an adjusted significance level of 0.05/
40359 = 1.24 × 10−6 after clinical factors are adjusted.
Table 1 summarizes the results for the 4 top SNPs.
The family-based association analysis identified no sig-
nificant SNPs. The smallest p value among all SNPs is
1.59 × 10−6, which is larger than the adjusted signifi-
cance level of 1.24 × 10−6. Table 2 summarizes the
details of the top 4 SNPs from family-based association
analyses.
After applying FDR control on the weighted p values
from the population-based association analysis, 1 SNP,
rs9828485, achieves significant level with an adjusted
p value of 0.0312. However, there is no significant SNP
if we apply ordinary FDR control (Benjamini-Hochberg)
to the raw p values from the family-based association
test. Table 3 provides more results.
Simulation results
We applied simulation with 10 different effect sizes of b
to assess the power under different effect sizes. We
chose bs as 0.1, 0.3, 0.4, 0.5, 0.6, 0.8, 0.9, 1.0, 1.5 and
2.0. Figure 2 shows the empirical powers. It is easy to
conclude that the power was improved by using the
WFDR approach.
Figure 1 Manhattan plot of family-based and population-based association tests for MAP.
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Discussion
In this study, we extended the WFDR to adjust p values
from the family-based association test by incorporating
the population-based association test. A simulation
study was conducted to examine the improvement of
statistical power of WFDR comparing FDR under differ-
ent effect sizes.
According to the simulation results, we believe that
the weighted method for FDR control improves statisti-
cal power if there is a correct assignment of weights as
we can see a big increase in the statistical power from
FDR to WFDR when the effect size between phenotype
and genotype is moderate. Although our study only
focused on continuous outcome, the method can also
be applied to other disease outcomes, such as binary
outcome. Further analysis and simulation could be
explored to assess the efficiency of the WFDR method
for binary outcome. We are further developing our
method for family-based association tests on the
nuclear family.
Conclusions
We propose a WFDR method to adjust p values for
family-based association test, which we believe we will
more powerful than FDR. Based on GAW18 data, we
evaluated the genetic association between each single
SNP from chromosome 3 and MAP using the family-
based association test for quantitative trait. Using ordin-
ary FDR to control for multiple testing, we found no
significant association. However, applying WFDR, we
found 1 SNP rs9828485 in gene CACNA2D3 that is
strongly associated with MAP. CACNA2D3 has been
reported to be associated with cardiac disease [8].
Because high blood pressure is a major risk factor for
cardiac disease, CACNA2D3 could also lead to blood
pressure.
Table 1 Top 4 SNPs from population-based association analysis
Chr SNP Gene BP Minor allele MAF (%) p Value
3 rs9828558 NA 23115291 G 33 9.14E-05
3 rs7616789 NA 27024158 T 26 2.05E-04
3 rs2700464 ULK4 41522811 T 19 2.53E-04
3 rs12634258 NA 61291738 T 38 9.87E-05
BP, base pair; MAF, minor allele frequency.
Table 2 Top 4 SNPs from family-based association analysis
Chr SNP Gene BP Minor allele MAF (%) p Value
3 rs17638423 LARS2 45466958 T 14 1.04E-04
3 rs9828485 CACNA2D3 54288475 A 19 1.59E-06
3 rs6650908 NA 65148368 G 33 9.30E-05
3 rs500857 CNTN3 74327008 G 42 1.52E-04
BP, base pair; MAF, minor allele frequency.
Table 3 Comparison of different p values for SNP rs9828485
SNP Gene BP Minor allele MAF (%) Pfam Ppop PFDR PWFDR
rs9828485 CACNA2D3 54288475 A 19 1.59E-06 0.05 0.0624 0.0321
BP, base pair; MAF, minor allele frequency; Pfam, p value for family-based test; Ppop, p value for population-based test; PFDR, p value false discovery rate; PWFDR, p
value for weighted false discovery rate.
Figure 2 Statistical power under different effect sizes by using
ordinary FDR and WFDR. The blue line represents the power by
using FDR and the red line is for WFDR.
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